News

ML-0022 Rev A Photo.jpg

Access Vascular Raises a New $6M Round of Funding

September 26, 2019

Access Vascular has raised a new round of funding! With this new round, the company is poised to launch the next generation of its FDA-cleared HydroPICC device, initiate the company’s first post-market registry study, and expedite new product development. Read the press release here.


LinkedIn.png

Access Vascular Awarded Breakthrough Technology Contract With Premier

September 20, 2019

Access Vascular is excited to announce that our company has been awarded a group purchasing agreement contract with Premier. This agreement allows Premier’s alliance of approximately 4,000 hospitals and 165,000 other providers to take advantage of special pricing and terms for our HydroPICC catheter. In benchtop studies, HydroPICC has demonstrated a 97% reduction in thrombus accumulation compared to traditional polyurethane catheters. Read the full press release here.


Capture.PNG

Interview with Physician from First HydroPICC Use

April 10, 2019

Earlier this year, Access Vascular’s HydroPICC device was first used in patients at Riverside Medical Center in Kankakee, IL. HydroPICC represents a new option for clinicians to address catheter-related thrombosis, and upcoming field evaluations of the device will seek to establish our new hydrogel material platform as the preferred option for venous access. Read about Dr. Arun Jagannathan’s experience using HydroPICC and his thoughts on the impact that the material could have across venous access.


 
Tip Occlusion Results.jpg

Access Vascular Publishes Results of Head-to-Head In Vitro Tip Occlusion Study

April 3, 2019

Access Vascular is pleased to announce the publication of head-to-head in vitro tip occlusion results comparing HydroPICC with the market leading catheter, PowerPICC (Becton Dickinson). In in vitro blood flow loop testing, HydroPICC exhibited a complete reduction in thrombotic occlusion rate when compared to the PowerPICC catheter. Read the full results here.


SIR_2019_BackTable_Podcast.JPG

Access Vascular Hosts Podcast on Difficult Venous Access

March 25, 2019

Access Vascular had the opportunity to host Dr. Jeffrey Chick and Dr. Arun Jagannathan at the company’s booth at the Society of Interventional Radiology 2019 conference for an engaging discussion on difficult venous access. The podcast was hosted by BackTable podcast, a premier source for information on tools and techniques for interventional radiologists. Listen to the podcast here.


190212_09.jpg

Access Vascular Begins First Clinical Use of HydroPICC

February 8, 2019

Riverside Medical Center became the first hospital to implant Access Vascular’s HydroPICC peripherally inserted central catheter (PICC). The device is designed from a novel biomaterial created to address the most common and costly complications plaguing the global venous access market.

Dr. Arun Jagannathan, one of the attending interventional radiologists who placed the initial devices, shared his enthusiasm for the novel device, noting, "Chronically ill patients require frequent and often long-term intravenous access which invariably results in destruction and eventual depletion of their vascular access options over time. This catheter represents the most significant advance in venous access technology that I've experienced since I started practicing over ten years ago. Due to the device’s lubriciousness, it may allow health care providers to mitigate venous access depletion."

Read the press release here.


Access Vascular Publishes In Vitro and In Vivo Results

September 15, 2018

Access Vascular has published the results of in-vitro and in-vivo studies of HydroPICC. HydroPICC showed an up to 30x reduction in thrombus accumulation versus polyurethane catheters and minimal formation of a fibrin sheath. Read the full results here.


FDA Clears AVI’s HydroPICC

February 22, 2018

MassDevice: Access Vascular, a medical device company reinventing venous access using proprietary material technology designed to reduce thrombus accumulation, announced today that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its lead product.

AVI raises $3.7M to Support HydroPICC

August 29, 2017

Access Vascular has announced US$3.7m in funding from individual investors and angelMD, an investment platform and marketplace connecting innovative medical start-ups, physicians, investors and industry partners. This financing will help support submission of a 510(k) application later this year, for Access Vascular’s lead product, the HydroPICC, a superior peripherally-inserted central catheter.